Status:

COMPLETED

Efficacy and Safety of F-18 FPCIT PET in Parkinson's Disease and Essential Tremor Patients

Lead Sponsor:

Asan Medical Center

Conditions:

Parkinson's Disease

Eligibility:

All Genders

40+ years

Phase:

PHASE3

Brief Summary

The purpose of this study is to determine whether F-18 FPCIT is effective and safe radiopharmaceutical for the objective diagnosis of Parkinson's disease.

Detailed Description

Parkinson's disease is a common neurodegenerative disorder with loss of dopaminergic terminals in the striatum. Essential tremor is one of the conditions most commonly misdiagnosed as parkinsonism, an...

Eligibility Criteria

Inclusion

  • Parkinson's disease
  • Male or female with age over 40 years
  • Clinical diagnosis of Parkinson's disease
  • Ability to give informed consent
  • Essential tremor
  • Male or female with age over 40 years
  • Clinical diagnosis of Essential tremor
  • Ability to give informed consent
  • Healthy volunteers
  • Male or female with age over 40 years
  • No any symptoms or sign suggesting Parkinson's disease or essential tremor
  • Ability to give informed consent

Exclusion

  • Parkinson's disease and essential tremor
  • Current pregnancy and breast feeding
  • Current or past medical history of cardiac and neuropsychiatric disease
  • Clinical evidence of dementia
  • Inability to hold antiparkinsonian medication
  • History of surgical therapy for tremor
  • Severe or unstable medical or psychiatric condition
  • Medication affecting CNS in last 6 months(e.g. CNS stimulants, sympathomimetics)
  • Prior participation in other research protocol within 30 days
  • Healthy volunteers
  • Current pregnancy and breast feeding
  • Current or past medical history of cardiac and neuropsychiatric disease
  • Severe or unstable medical or psychiatric condition
  • Drug abuse or medication affecting CNS (e.g. CNS stimulants, sympathomimetics) within 6 months
  • Prior participation in other research protocol within 30 days

Key Trial Info

Start Date :

November 1 2006

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 1 2007

Estimated Enrollment :

78 Patients enrolled

Trial Details

Trial ID

NCT00468078

Start Date

November 1 2006

End Date

October 1 2007

Last Update

January 13 2016

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Asan Medical Center

Seoul, South Korea, 138-736

Efficacy and Safety of F-18 FPCIT PET in Parkinson's Disease and Essential Tremor Patients | DecenTrialz